• Journal of Ocular Pharmacology and Therapeutics Peer-Reviewed Journal Publishes NB2222 Ocular Bioavailability Data LONG BEACH, CA, June 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Emerald Bioscience, Inc. (EMBI), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, today announced that newly published scientific data highlight… Read More..

  • Adds Insurtech Solutions to Rokk3r Platform Miami, FL, June 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Rokk3r Inc. (OTC Pink: ROKK) (“Rokk3r”), a global idea-to-exit consulting services company that leverages exponential technologies to generate value, today announced its acquisition of Bullfrog Ventures (“Bullfrog”), an incubator specializing in insurance and… Read More..

  • We are pleased to share a poster presentation made at the 2019 ASCO Annual Meeting. This presentation contains work by Northwestern University clinicians and scientists demonstrating biodistribution and tolerability data from a Phase 0 first-in-human study of NU-0129, a gold-based SNA targeting the Bcl2L12 gene. The study was conducted in… Read More..

  • Latest Tweets